Keyphrases
Clinical Significance
100%
Neoadjuvant Therapy
100%
Tumor-infiltrating Immune Cells
100%
HER2-negative Breast Cancer
100%
Stromal Tumor-infiltrating Lymphocytes
100%
Pathological Complete Response
75%
Tumor
50%
Cluster Analysis
50%
Event-free Survival
50%
CD68
50%
CD1a
50%
Luminal B
50%
Immunoscore
50%
Clinical Outcomes
25%
High Risk
25%
Blood Samples
25%
Breast Cancer
25%
Low Risk
25%
Therapy Response
25%
Treatment Response
25%
Flow Cytometry
25%
Peripheral Blood
25%
Tumor Tissue
25%
CD-8
25%
CD20
25%
Immune Markers
25%
Tumor Microenvironment
25%
Neoadjuvant Setting
25%
Patient Tumor
25%
Triple Negative
25%
Myeloid-derived Suppressor Cells
25%
Circulating Exosomes
25%
De-escalation Therapy
25%
Immune Pattern
25%
Medicine and Dentistry
Neoplasm
100%
Breast Cancer
100%
Neoadjuvant Therapy
100%
Immunocompetent Cell
100%
Tumor Infiltrating Lymphocyte
57%
Stromal Tumor
57%
Treatment Response
28%
Event Free Survival
28%
Cluster Analysis
28%
Chlordane
28%
Flow Cytometry
14%
Mediator
14%
Triple Negative Breast Cancer
14%
CD20
14%
Cell Marker
14%
Immunity
14%
Tumor Microenvironment
14%
CD8 Antigen
14%
Exosome
14%
Myeloid-Derived Suppressor Cell
14%
Immunology and Microbiology
Immunocompetent Cell
100%
Tumor-Infiltrating Lymphocytes
100%
CD68
50%
Event Free Survival
50%
Myeloid-Derived Suppressor Cell
25%
CD4
25%
CD8
25%
Mediator
25%
CD20
25%
Cell Marker
25%
Exosome
25%
Immunity
25%